PRESS RELEASE published on 09/27/2024 at 11:24, 1 year 10 months ago HALF-YEAR_FINANCIAL_REPORT_JUNE_2024
BRIEF published on 09/23/2024 at 19:41, 1 year 10 months ago GenSight Biologics Reports Interim Financial Results for H1 2024 Financial Results Cash Management LUMEVOQ® Early Access Program R&D Expenses
PRESS RELEASE published on 09/23/2024 at 19:36, 1 year 10 months ago Inside Information / News release on accounts, results GenSight Biologics reports interim financial results for the first half of 2024, highlighting optimized cash management, extension of cash runway, and upcoming LUMEVOQ® drug product release Cash Management GenSight Biologics Interim Financial Results LUMEVOQ® Drug Product Release
BRIEF published on 09/17/2024 at 14:45, 1 year 10 months ago Goldman Sachs sells its GENSIGHT BIOLOGICS SA shares Euronext Paris Goldman Sachs Crossing Thresholds Transfer Of Shares GenSight Biologics
BRIEF published on 07/23/2024 at 07:35, 2 years ago GenSight Biologics Reports Financial Position and Business Progress Gene Therapy Financial Update GenSight Biologics LUMEVOQ Early Access Program
PRESS RELEASE published on 07/23/2024 at 07:30, 2 years ago Inside Information / News release on accounts, results GenSight Biologics reports cash position of €6.9 million as of June 30, 2024, with potential over 100 vials available upon Q3 resumption of early access program. Company confirms sufficient working capital and successful blending step for LUMEVOQ drug product Working Capital Business Update Cash Position GenSight Biologics LUMEVOQ Drug Product
BRIEF published on 07/11/2024 at 07:35, 2 years ago GenSight Biologics Launches Newsletter for Retail Investors Financial Updates Gene Therapy Retail Investors LUMEVOQ® Optogenetics
PRESS RELEASE published on 07/11/2024 at 07:30, 2 years ago Inside Information / Other news releases GenSight Biologics launches a newsletter for retail investors providing updates, news articles, conferences, and financial figures in French, available via subscription on the company's website Subscription Retail Investors Newsletter French GenSight Biologics
BRIEF published on 06/20/2024 at 07:35, 2 years 1 month ago GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates Gene Therapy Operational Update GenSight Biologics Financial Negotiation
PRESS RELEASE published on 06/20/2024 at 07:30, 2 years 1 month ago Inside Information / Other news releases GenSight Biologics renegotiates financial obligations and provides operational updates, with successful capital increases enhancing short-term flexibility Financial Obligations Operational Updates GenSight Biologics Capital Increases Gene Therapies
Published on 08/01/2026 at 01:20, 1 day 17 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 17 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 18 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 19 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 10 hours 24 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 1 day 2 hours ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 22 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 23 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 1 day 21 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 23 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026